<DOC>
	<DOCNO>NCT00096798</DOCNO>
	<brief_summary>The purpose study examine effectiveness ethyl-eicosapentanoic acid ( ethyl-EPA ) , omega-3 fatty acid , treat depression .</brief_summary>
	<brief_title>Ethyl Eicosapentanoic Acid ( Ethyl-EPA ) Treating Major Depression</brief_title>
	<detailed_description>Evidence suggest omega-3 fatty acid may help reduce symptom depression . This study determine whether ethyl-EPA , omega-3 fatty acid , use safely effectively treat major depression . Participants randomly assign receive either ethyl EPA-containing pill placebo daily 8 week . Each week , participant ask complete questionnaire use assess severity depression .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>Major depressive disorder Serious comorbid psychiatric disorder Unstable medical illness Prior use omega3 fatty acid product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Fatty Acids , Omega-3</keyword>
	<keyword>Antidepressive Agents</keyword>
	<keyword>Eicosapentanoic Acid</keyword>
</DOC>